Download
https://www.ndtvprofit.com/business/dr-reddys-wins-rulings-over-three-patents-for-suboxone-drug?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Dr. Reddy sees an upside of additional Rs 30 EPS, according to Credit Suisse, after it won the Suboxone case.
Share